[미국특허]
Film compositions for delivery of actives
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/14
A61K-009/00
A61F-013/00
출원번호
US-0779316
(2010-05-13)
등록번호
US-8663687
(2014-03-04)
발명자
/ 주소
Myers, Garry L.
Fuisz, Richard C.
출원인 / 주소
MonoSol Rx, LLC
대리인 / 주소
Hoffmann & Baron, LLP
인용정보
피인용 횟수 :
14인용 특허 :
136
초록▼
The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film.
The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films contain at least one active agent, which may be administered to a user topically, transmucosally, vaginally, ocularly, aurally, nasally, transdermally or orally.
대표청구항▼
1. A self-supporting film composition comprising: (i) a water soluble polymer composition comprising polyethylene oxide and a saccharide-based polymer; and(ii) a topical agent;wherein said topical agent is in the form of a small-scale particle selected from the group consisting of at least one type
1. A self-supporting film composition comprising: (i) a water soluble polymer composition comprising polyethylene oxide and a saccharide-based polymer; and(ii) a topical agent;wherein said topical agent is in the form of a small-scale particle selected from the group consisting of at least one type of nanoparticle, at least one type of micelle, at least one type of microdroplet, at least one type of microparticle, at least one type of liquid crystal, and combinations thereof, andwherein said small-scale particle of at least one agent is uniformly distributed in the film composition and uniformity is measured by equally sized individual unit doses which do not vary by more than 10% by weight of said small-scale particle of at least one agent from a desired dose. 2. The composition of claim 1, wherein said topical agent is in the form of at least one type of liquid crystal. 3. The composition of claim 1, wherein said topical agent is in the form of at least one type of micelle. 4. The composition of claim 1, wherein said topical agent is bound to at least one ligand. 5. A dosage composition comprising: a. A self-supporting film comprising: i. At least one polymer; andii. At least one agent;wherein said at least one agent is in the form of a small-scale particle selected from the group consisting of at least one type of nanoparticle, at least one type of micelle, at least one type of microdroplet, at least one type of microparticle, at least one type of liquid crystal, and combinations thereof, andwherein said small-scale particle of at least one agent is uniformly distributed in the dosage composition and uniformity is measured by equally sized individual unit doses which do not vary by more than 10% by weight of said small-scale particle of at least one agent from a desired dose. 6. The composition of claim 5, wherein said agent is in the form of at least one type of liquid crystal. 7. The composition of claim 5, wherein said agent is in the form of at least one type of micelle. 8. The composition of claim 5, wherein said agent is bound to at least one ligand. 9. A method of forming a self-supporting film dosage composition, comprising the steps of: a. Providing a polymeric matrix;b. Forming a small-scale form of at least one agent;c. Dispersing said small-scale form of at least one agent throughout said polymeric matrix;d. Drying said polymeric matrix so as to form a self-supporting film dosage composition comprising said small-scale form of at least one agent;wherein said small-scale form of at least one agent is selected from the group consisting of at least one type of nanoparticle, at least one type of microparticle, at least one type of microdroplet, at least one type of micelle, at least one type of liquid crystal, and combinations thereof, andwherein said small-scale form of at least one agent is uniformly distributed in the film dosage composition and uniformity subsequent to dispersing and drying is measured by equally sized individual unit doses which do not vary by more than 10% by weight of said small-scale form of at least one agent from a desired dose. 10. The method of claim 9, wherein said agent is in the form of at least one type of microdroplet. 11. The method of claim 9, wherein said agent is in the form of at least one type of micelle. 12. The method of claim 9, wherein said small-scale form of at least one agent is formed through emulsion processing. 13. The method of claim 9, wherein said small-scale form of at least one agent is formed through milling. 14. The method of claim 9, wherein said small-scale form of at least one agent is formed through processing via a microfluidics pumping apparatus. 15. The method of claim 9, wherein said small-scale form of at least one agent is bound to at least one ligand. 16. The method of claim 9, wherein said step of drying said polymeric matrix comprises heating said polymeric matrix so as to rapidly form a visco-elastic mass to maintain a uniform distribution of said agent by locking-in or preventing migration of said agent within said visco-elastic mass within the first 10 minutes or less to maintain a uniform distribution of said agent by locking-in or preventing migration of said agent within said visco-elastic mass. 17. The method of claim 16, wherein said polymeric matrix containing said agent varies no more than 10% by weight of said agent throughout said polymeric matrix. 18. The method of claim 16, wherein said step of drying said polymeric matrix further comprises further drying said visco-elastic mass so as to provide a self-supporting film dosage composition having a solvent content of 10% or less. 19. The method of claim 16, wherein said step of forming a visco-elastic mass occurs within the first 0.5 to about 10 minutes of heating to maintain a uniform distribution of said agent by locking-in or preventing migration of said agent within said visco-elastic mass. 20. The method of claim 19, wherein said polymeric matrix containing said agent varies no more than 10% by weight of said agent throughout said polymeric matrix. 21. The method of claim 19, wherein said step of drying said polymeric matrix further comprises further drying said visco-elastic mass so as to provide a self-supporting film dosage composition having a solvent content of 10% or less. 22. The method of claim 9, wherein said small-scale form of at least one agent is formed through processing via a high shear apparatus. 23. The method of claim 9, wherein said small-scale form of said agent is in the form of at least one liquid crystal. 24. A method of forming a self-supporting film dosage composition, comprising the steps of: a. Providing a polymeric matrix;b. Forming a small-scale form of at least one agent;c. Applying said small-scale form of at least one agent to said polymeric matrix via deposition; andd. Drying said polymeric matrix so as to form a self-supporting film dosage composition comprising said small-scale form of at least one agent,wherein said small-scale form of at least one agent is selected from the group consisting of at least one type of nanoparticle, at least one type of micelle, at least one type of microdroplet, at least one type of microparticle, at least one type of liquid crystal, and combinations thereof, andwherein said small-scale form of at least one agent is uniformly distributed on the film dosage composition and uniformity subsequent to applying and drying is measured by equally sized individual unit doses which do not vary by more than 10% by weight of said small-scale form of at least one agent from a desired dose. 25. The method of claim 24, wherein said agent is in the form of at least one type of microdroplet. 26. The method of claim 24, wherein said agent is in the form of at least one type of micelle. 27. The method of claim 24, wherein said small-scale form of at least one agent is formed through emulsion processing. 28. The method of claim 24, wherein said small-scale form of at least one agent is formed through milling. 29. The method of claim 24, wherein said small-scale form of at least one agent is formed through processing via a microfluidics pumping apparatus. 30. The method of claim 24, wherein said small-scale form of at least one agent is bound to at least one ligand. 31. The method of claim 24, wherein said small-scale form of at least one agent is formed through processing via a high shear apparatus. 32. The method of claim 24, wherein said small-scale form of said agent is in the form of at least one liquid crystal.
Babaian Eduard A. (Moscow SUX) Gerasimova Galina A. (Moscow SUX) Davydov Anatoly B. (Moscow SUX) Utyamyshev Rustam I. (Moscow SUX) Khromov Gennady L. (Moscow SUX) Metelitsa Vladimir I. (Moscow SUX) V, Antianginal film and method of treating ischemic heart disease.
Hijiya Hiromi (Okayama JPX) Miyake Toshio (Okayama JPX), Association complex comprising pullulan and polyethylene glycol, and preparation and uses of the same.
Rel Bernhard (Knigstein/Taunus DEX) Petri Walter (Niedernhausen/Taunus DEX), Base for mucosal and denture adhesive pastes, a process for the preparation thereof, and pastes having this base.
Schiraldi Michael T. (East Brunswick NJ) Perl Martin M. (Brooklyn NY) Rubin Howard (Rockaway NJ), Bioadhesive extruded film for intra-oral drug delivery and process.
Schiraldi Michael T. (East Brunswick NJ) Perl Martin M. (Brooklyn NY) Rubin Howard (Rockaway NJ), Bioadhesive extruded film for intra-oral drug delivery and process.
Michael A. Repka ; Staci L. Repka ; James W. McGinity, Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof.
Norton Richard L. (Fort Collins CO) Knight Stephen Michael Gregory (Fort Collins CO) Tipton Arthur J. (Birmingham AL), Biodegradable polymeric composition.
Fischel-Ghodsian Fariba (2122 Century Park La. ; #104 Los Angeles CA 90067), Device for controlled release of vaporous medications through nasal route.
Hymes Alan C. (Minnetonka MN) Ong Lincoln T. (Minnetonka MN) Persons Garry R. (Edina MN), Drug dispensing device for transdermal delivery of medicaments.
Eury Robert P. (Cupertino CA) Garguilo Darlene (Fremont CA) Villareal Plaridel (San Jose CA), Drug loaded polymeric material and method of manufacture.
Jevne Allan H. (Anoka MN) Vegoe Brett R. (Brooklyn Park MN) Holmblad Carolann M. (Cambridge MN) Cahalan Patrick T. (Champlin MN), Hydrophilic pressure sensitive biomedical adhesive composition.
Broberg Berndt F. J. (Sdertlje SEX) Evers Hans C. A. (Sdertlje SEX), Local anesthetic mixture for topical application and method for obtaining local anesthesia.
Leusner Bernd (Leverkusen DEX) Heiss Rdiger (Grefrath DEX) Pelster Bernd (St. Augustin DEX) Fischer Wolfgang (Bergisch Gladbach DEX) Ohm Ulrich (Odenthal DEX), Medicaments for the region of the oral cavity.
Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
Kizawa Hidenori (Tokyo JPX) Fujiyama Norimasa (Tokyo JPX) Kobayashi Jitsuo (Kanagawa JPX) Ito Akinori (Niigata JPX), Mucous membrane-adhering film preparation and process for its preparation.
Sorrentino James V. (Wilton CT) Kelleher William J. (Storrs CT) Moye Jeanne O. (Fairfield CT), Pharmaceutical compositions containing dyclonine HC1 and phenol.
Santus Giancarlo (Milan ITX) Bottoni Giuseppe (Bergamo ITX) Sala Giovanni (Verona ITX), Pharmaceutical controlled-release composition with bioadhesive properties.
Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Noguchi Toshihide (Tokyo JPX) Izumizawa Katsunori (Yokohama JPX) Kinoshita ; deceased Shiro (late of Tokyo JPX by Kimiko Kinoshita ; Atsuhiro Kinosh, Pharmaceutical preparation for remedy of periodontal disease and process for production thereof.
Vert Michel (Mont-Saint-Aignan FRX) Mauduit Jacques (Bacqueville En Caux FRX) Bukh Niels (Hellerup DKX), Polylactic acid-based implant susceptible of bioresorption containing and antibiotic.
Leclef Brigitte (Brussels BEX) Cerfontaine Patrick (Brussels BEX) Nicolas Jean-Marie (Overijse BEX) Wantier Henri (Dour BEX) Trouet Andr (Winksele Herent BEX), Process for preparing lipid microparticles.
Schmidt Wolfgang (Reembroden 44 D-2000 Hamburg 63 DEX), Process for producing an administration or dosage form for drugs, reagents or other active ingredients.
Devissaguet Jean-Philippe (Neuilly sur Seine FRX) Fessi Hatem (Paris FRX) Puisieux Francis (Maisons Alfort FRX), Process for the preparaton of dispersible colloidal systems of a substance in the form of nanocapsules.
Horstmann Michael (Neuwied DEX) Laux Wolfgang (Dietz DEX) Hungerbach Stefan (Nortershausen DEX), Rapidly disintegrating sheet-like presentations of multiple dosage units.
Chang Yunik (Lakewood NJ) Patel Dinesh C. (Murray UT), Skin penetration enhancement using free base and acid addition salt combinations of active agents.
Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Yamashita Gentaro (Koganei JPX), Slow-releasing medical preparation to be administered by adhering to a wet mucous surface.
Wheatley Margaret A. (Arlington MA) Langer Robert S. (Somerville MA) Eisen Herman N. (Waban MA), System for delayed and pulsed release of biologically active substances.
AF Ekenstam Bo T. (Box 721 Hjlteby SEX S-440 74) Aberg Gunnar A. K. (Utsiktsvgen 7 Falkenberg SEX S-311 00), Therapeutically active, substituted piperidines and pyrrolidines therapeutic compositions thereof and methods of use the.
Yang,Robert K.; Fuisz,Richard C.; Myers,Gary L.; Fuisz,Joseph M., Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom.
Heiber Sonia J. (Salt Lake City UT) Ebert Charles D. (Salt Lake City UT) Dave Sirish C. (Salt Lake City UT), Transmucosal delivery of macromolecular drugs.
Biegajski James E. (Foster City CA) Venkatraman Subbu S. (Palo Alto CA) Scott Ann M. (Mountain View CA), Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavi.
Fuisz, Richard C.; Fuisz, Joseph M., Package, system and methods for custody and control of drugs, and method and composition for making an oral soluble film, containing at least one active agent.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.